GB1358001A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB1358001A GB1358001A GB1928372A GB1928372A GB1358001A GB 1358001 A GB1358001 A GB 1358001A GB 1928372 A GB1928372 A GB 1928372A GB 1928372 A GB1928372 A GB 1928372A GB 1358001 A GB1358001 A GB 1358001A
- Authority
- GB
- United Kingdom
- Prior art keywords
- methaqualone
- april
- pharmaceutical compositions
- drug
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000011347 resin Substances 0.000 abstract 2
- 229920005989 resin Polymers 0.000 abstract 2
- JEYCTXHKTXCGPB-UHFFFAOYSA-N Methaqualone Chemical compound CC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C JEYCTXHKTXCGPB-UHFFFAOYSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 abstract 1
- 229960002803 methaqualone Drugs 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU63060 | 1971-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1358001A true GB1358001A (en) | 1974-06-26 |
Family
ID=19726690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1928372A Expired GB1358001A (en) | 1971-04-26 | 1972-04-26 | Pharmaceutical compositions |
Country Status (6)
| Country | Link |
|---|---|
| CH (1) | CH540695A (https=) |
| DE (1) | DE2220504A1 (https=) |
| FR (1) | FR2134503B1 (https=) |
| GB (1) | GB1358001A (https=) |
| LU (1) | LU63060A1 (https=) |
| NL (1) | NL7205573A (https=) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993007860A1 (en) | 1991-10-24 | 1993-04-29 | Kabi Pharmacia Ab | New drug formulations with ion-exchangers |
| US8062667B2 (en) | 2006-03-16 | 2011-11-22 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US8999386B2 (en) | 2012-08-15 | 2015-04-07 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
| US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
| US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
| US12458592B1 (en) | 2017-09-24 | 2025-11-04 | Tris Pharma, Inc. | Extended release amphetamine tablets |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1998200A (en) * | 1999-01-07 | 2000-07-24 | Elan Corporation, Plc | Multiparticulate oral dosage forms |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE560809A (https=) * | ||||
| FR7017E (https=) * |
-
1971
- 1971-04-26 LU LU63060D patent/LU63060A1/xx unknown
-
1972
- 1972-04-21 CH CH598872A patent/CH540695A/fr not_active IP Right Cessation
- 1972-04-25 NL NL7205573A patent/NL7205573A/xx unknown
- 1972-04-25 FR FR7214686A patent/FR2134503B1/fr not_active Expired
- 1972-04-26 GB GB1928372A patent/GB1358001A/en not_active Expired
- 1972-04-26 DE DE2220504A patent/DE2220504A1/de active Pending
Cited By (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993007860A1 (en) | 1991-10-24 | 1993-04-29 | Kabi Pharmacia Ab | New drug formulations with ion-exchangers |
| US5643560A (en) * | 1991-10-24 | 1997-07-01 | Pharmacia & Upjohn Ab | Drug formulation with ion-exchangers |
| US9549989B2 (en) | 2006-03-16 | 2017-01-24 | Tris Pharma, Inc | Modified release formulations containing drug-ion exchange resin complexes |
| US10668163B2 (en) | 2006-03-16 | 2020-06-02 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US8337890B2 (en) | 2006-03-16 | 2012-12-25 | Tris Pharma Inc | Modified release formulations containing drug-ion exchange resin complexes |
| US8491935B2 (en) | 2006-03-16 | 2013-07-23 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US8597684B2 (en) | 2006-03-16 | 2013-12-03 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US8747902B2 (en) | 2006-03-16 | 2014-06-10 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US8790700B2 (en) | 2006-03-16 | 2014-07-29 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US8883217B2 (en) | 2006-03-16 | 2014-11-11 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US9675704B2 (en) | 2006-03-16 | 2017-06-13 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US10933143B2 (en) | 2006-03-16 | 2021-03-02 | Tris Pharma, Inc | Modified release formulations containing drug-ion exchange resin complexes |
| US9198864B2 (en) | 2006-03-16 | 2015-12-01 | Tris Pharma, Inc | Modified release formulations containing drug-ion exchange resin complexes |
| US8062667B2 (en) | 2006-03-16 | 2011-11-22 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US9522191B2 (en) | 2006-03-16 | 2016-12-20 | Tris Pharma, Inc. | Modified release formulations containing drug—ion exchange resin complexes |
| US10172958B2 (en) | 2006-03-16 | 2019-01-08 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US8202537B2 (en) | 2006-03-16 | 2012-06-19 | Tris Pharma Inc | Modified release formulations containing drug-ion exchange resin complexes |
| US10086087B2 (en) | 2006-03-16 | 2018-10-02 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| US9675703B2 (en) | 2006-03-16 | 2017-06-13 | Tris Pharma, Inc | Modified release formulations containing drug - ion exchange resin complexes |
| US11103494B2 (en) | 2012-08-15 | 2021-08-31 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
| US9180100B2 (en) | 2012-08-15 | 2015-11-10 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
| US9844545B2 (en) | 2012-08-15 | 2017-12-19 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
| US9545399B2 (en) | 2012-08-15 | 2017-01-17 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
| US10507203B2 (en) | 2012-08-15 | 2019-12-17 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
| US8999386B2 (en) | 2012-08-15 | 2015-04-07 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
| US9844544B2 (en) | 2012-08-15 | 2017-12-19 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
| US11633389B2 (en) | 2012-08-15 | 2023-04-25 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
| US9295642B2 (en) | 2012-08-15 | 2016-03-29 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
| US11103495B2 (en) | 2012-08-15 | 2021-08-31 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
| US10857143B2 (en) | 2012-08-15 | 2020-12-08 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
| US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
| US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
| US12076441B2 (en) | 2017-09-24 | 2024-09-03 | Tris Pharma, Inc. | Extended release amphetamine tablets |
| US12458592B1 (en) | 2017-09-24 | 2025-11-04 | Tris Pharma, Inc. | Extended release amphetamine tablets |
Also Published As
| Publication number | Publication date |
|---|---|
| CH540695A (fr) | 1973-08-31 |
| FR2134503A1 (https=) | 1972-12-08 |
| NL7205573A (https=) | 1972-10-30 |
| LU63060A1 (https=) | 1971-08-26 |
| DE2220504A1 (de) | 1973-02-15 |
| FR2134503B1 (https=) | 1976-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1330878A (en) | Ketamine resolution | |
| FI865227A0 (fi) | Foerfarande foer framstaellning av ett depot-preparat. | |
| IL38571A0 (en) | 5-pyrrolidone-(2)-carboxylic acid esters and their manufacture | |
| GB1358001A (en) | Pharmaceutical compositions | |
| IL35564A0 (en) | Esters of substituted anthranilic acid,their preparation and pharmaceutical compositions containing them | |
| IL40685A0 (en) | Pharmaceutical compositions for the dissolution of renal calculi and their preparation | |
| GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
| IL37013A0 (en) | Basically substituted alkylidene-aminooxyalkyl carboxylic acid esters,their preparation and pharmaceutical compositions containing them | |
| GB1402691A (en) | Composition of 4-biphenyl acetic acid | |
| KE2760A (en) | Phenylformamidine carboxylic acid esters the preparation thereof and their use as pesticides | |
| IL40110A (en) | 1-imidazolyl-methanephosphonic acid esters,their production and pharmaceutical compositions containing them | |
| IE34730B1 (en) | Indomethacin suppositories | |
| GB1227830A (https=) | ||
| GB1311015A (en) | Pharmaceutical compositions and a process for the manufacture thereof | |
| GB1321419A (en) | Pharmaceutical composition | |
| IL33937A0 (en) | O-chloroalkyl-and o-bromoalkyl-s-benzyl-s'-alkyl-dithiophosphoric acid esters,their preparation and their use as pesticides | |
| GB1254057A (en) | Improvements in or relating to therapeutical composition containing vincamine | |
| BE758838A (fr) | Esters d'acides carboxyliques heterocyliques et medicaments renfermant de telles substances | |
| IL33731A0 (en) | O,o-dialkyl-s-(1,2,2-trichloroethyl)-thionothiolphosphoric acid esters and o-alkyl-s-(1,2,2-trichloroethyl)-alkanethionothiolphosphonic acid esters,their preparation and use as insecticides | |
| GB1400842A (en) | Oxaprostanoic acid derivatives and pharmaceutical compositions containing the same | |
| GB1417817A (en) | Substituted acetic acid cyclohexyl esters the preparation thereof and pharmaceutical compositions containing them | |
| GB1220818A (en) | New medicinal composition | |
| PHILLIPS | COMPETENT BARGAIN | |
| CA996572A (en) | Process for the preparation of acrylate and methacrylate esters | |
| CA953508A (en) | Production of smooth and spheroidal ferrosilicon particles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |